'A Moratorium on Human Gene Editing Is Critical'

Rudolf Jaenisch, MD, is a Founding Member, Whitehead Institute for Biomedical Research, and President, the International Society for Stem Cell Research It has been just over a half-century since scientists solved the structure of DNA, and since that time, we have been fascinated by what the DNA encodes, how it is passed on from one generation to the next and what makes each of us unique. Technologies to introduce DNA changes have been used to study the function of genes and the proteins they encode, to identify genetic causes of disease and to develop better ways to treat them.
http://ift.tt/1zSHCcc

Stem Cell Injection May Reverse Age-Related Vision-Loss, Researchers Reveal

A study published in the journal Stem Cell discovered that administering stem cells into the eye through injection can delay or prevent the effects of early-stage macular degeneration associated with ageing. According to lead researcher Shaomei Wang of Cedars-Sinai, their study is the first of its kind in terms of presenting a vision preservation with a single stem cell injection.
http://ift.tt/1Hy8Ivu

Rejuvenation Biotechnology Update for Q2 2015

Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction. But over the long haul all that really matters is medical biotechnology: progress towards repair and reversal of the known root causes of aging.
http://ift.tt/1Go2iAt

Hamilton Thorne Reports Record Revenue; Operating Leverage Drives...

The Company's strategy to focus on its core markets continues to generate strong sales growth and substantial improvements in financial performance. Sales increased 16% to a record $8.7 million for the year, led by strong growth in sales of IVOS II image analysis products and LYKOS clinical laser systems, as well as increased revenues from after-sale services.
http://ift.tt/1HtTskL

Researchers in China have manipulated human embryos

Long a no-no in the scientific community, researchers in China have for the first time modified the DNA of a human embryo. Not surprisingly, other scientists are not happy about it.
http://ift.tt/1aW1Aw5

Modulating the Vascular Response to Limb Ischemia: Angiogenic and...

Correspondence to John P. Cooke, MD, Chair, Department of Cardiovascular Sciences, Houston Methodist Research Institute, 6670 Bertner Ave, Mail Stop R10-South, Houston, TX 77030. E-mail The age-adjusted prevalence of peripheral arterial disease in the US population has been estimated to approach 12%.
http://ift.tt/1PqWVlr

Chinese scientists first to genetically modify human embryos, critics lash out

In a move that is both groundbreaking and extremely controversial, a group of Chinese scientists released a study detailing their experiments with genetically engineered human embryos. Editing the DNA of humans has long been considered an ethical taboo in the field of science, and the experiments performed by Junjiu Huang and his colleagues at the Sun Yat-sen University in Guangzhou, China have been heavily criticized by both scientists and watchdog groups on the lookout for violations of human ethics.
http://ift.tt/1aWgRge